Cross-talk between the kidney and the cardiovascular system

被引:134
作者
Amann, Kerstin
Wanner, Christoph
Ritz, Eberhard
机构
[1] Univ Erlangen Nurnberg, Dept Pathol, Erlangen, Germany
[2] Univ Wurzburg, Dept Internal Med, Wurzburg, Germany
[3] Ruprecht Karls Univ Heidelberg, Dept Internal Med, Heidelberg, Germany
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2006年 / 17卷 / 08期
关键词
D O I
10.1681/ASN.2006030204
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In recent years, increasing evidence has been provided that even minor renal dysfunction is a powerful cardiovascular risk factor that induces typical cardiovascular alterations and thus predisposes to coronary heart disease as well as to noncoronary cardiovascular problems. This first had been noted in patients with diabetes but now has been confirmed amply in patients without diabetes as well. Numerous heterogeneous abnormalities have been described in patients with early renal dysfunction (e.g., microalbuminuria, reduced estimated GFR). One final common pathway seems to be endothelial cell dysfunction. The link between albuminuria and generalized endothelial cell dysfunction (as indicated by diminished flow-mediated vasodilation, markers of endothelial cell dysfunction, sloughed off endothelial cells, and high transcapillary albumin escape rate) is unclear. In patients with early renal dysfunction, a long list of classical and nonclassical cardiovascular risk factors have been identified: Elevated asymmetric dimethyl-L-arginine concentrations, markers of microinflammation, oxidative stress, features of metabolic syndrome, abnormal adipokine concentrations, dyslipidemia, inappropriate activation of the renin-angiotensin system, and sympathetic overactivity. The mechanisms that link dysfunction of the kidney and the cardiovascular system are being sought. The most interesting unifying concept, however, is deranged fetal programming linking nephron underclosing to the increased cardiovascular risk.
引用
收藏
页码:2112 / 2119
页数:8
相关论文
共 107 条
[21]   Accelerated coronary artery calcification in mildly reduced renal function of high-risk hypertensives: a 3-year prospective observation [J].
Bursztyn, M ;
Motro, M ;
Grossman, E ;
Shemesh, J .
JOURNAL OF HYPERTENSION, 2003, 21 (10) :1953-1959
[22]   The apolipoprotein E knockout mouse:: A model documenting accelerated atherogenesis in uremia [J].
Buzello, M ;
Törnig, J ;
Faulhaber, J ;
Ehmke, H ;
Ritz, E ;
Amann, K .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (02) :311-316
[23]   RENAL AFFERENT DENERVATION PREVENTS HYPERTENSION IN RATS WITH CHRONIC-RENAL-FAILURE [J].
CAMPESE, VM ;
KOGOSOV, E .
HYPERTENSION, 1995, 25 (04) :878-882
[24]   The metabolic syndrome and chronic kidney disease in US adults [J].
Chen, J ;
Muntner, P ;
Hamm, LL ;
Jones, DW ;
Batuman, V ;
Fonseca, V ;
Whelton, PK ;
He, J .
ANNALS OF INTERNAL MEDICINE, 2004, 140 (03) :167-174
[25]   Proteinuria as a risk factor for cardiovascular disease and mortality in older people: A prospective study [J].
Culleton, BF ;
Larson, MG ;
Parfrey, PS ;
Kannel, WB ;
Levy, D .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (01) :1-8
[26]   Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis - Genetic and physiological evidence [J].
Dayoub, H ;
Achan, V ;
Adimoolam, S ;
Jacobi, J ;
Stuehlinger, MC ;
Wang, BY ;
Tsao, PS ;
Kimoto, M ;
Vallance, P ;
Patterson, AJ ;
Cooke, JP .
CIRCULATION, 2003, 108 (24) :3042-3047
[27]   Increased urinary albumin excretion, insulin resistance, and related cardiovascular risk factors in patients with type 2 diabetes - Evidence of a sex-specific association [J].
De Cosmo, S ;
Minenna, A ;
Ludovico, O ;
Mastroianno, S ;
Di Giorgio, A ;
Pirro, L ;
Trischitta, V .
DIABETES CARE, 2005, 28 (04) :910-915
[28]   Uremia causes endothelial progenitor cell deficiency [J].
de Groot, K ;
Bahlmann, FH ;
Sowa, J ;
Koenig, J ;
Menne, J ;
Haller, H ;
Fliser, D .
KIDNEY INTERNATIONAL, 2004, 66 (02) :641-646
[29]   ALBUMINURIA REFLECTS WIDESPREAD VASCULAR DAMAGE - THE STENO HYPOTHESIS [J].
DECKERT, T ;
FELDTRASMUSSEN, B ;
BORCHJOHNSEN, K ;
JENSEN, T ;
KOFOEDENEVOLDSEN, A .
DIABETOLOGIA, 1989, 32 (04) :219-226
[30]   Endothelin and cardiovascular remodelling in end-stage renal disease [J].
Demuth, K ;
Blacher, J ;
Guerin, AP ;
Benoit, MO ;
Moatti, N ;
Safar, ME ;
London, GM .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (02) :375-383